Pharmacokinetics of Low Dose Raltegravir.

Trial Profile

Pharmacokinetics of Low Dose Raltegravir.

Phase of Trial: Phase II

Latest Information Update: 21 Mar 2013

At a glance

  • Drugs Raltegravir (Primary)
  • Indications HIV-1 infections
  • Focus Pharmacokinetics
  • Most Recent Events

    • 02 Mar 2011 Results presented at the 18th Conference on Retroviruses and Opportunistic Infections.
    • 04 Feb 2011 Status changed from recruiting to completed as reported by
    • 16 Jul 2010 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top